Husain Sattar to Antineoplastic Agents
This is a "connection" page, showing publications Husain Sattar has written about Antineoplastic Agents.
Connection Strength
0.141
-
Treatment Efficacy Score-continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials. Ann Oncol. 2022 08; 33(8):814-823.
Score: 0.095
-
Phase II trial of temsirolimus in patients with metastatic breast cancer. Breast Cancer Res Treat. 2012 Nov; 136(2):355-63.
Score: 0.046